Breaking News

ProBioGen Expands Protein & Virus Manufacturing at Its Berlin HQ

Commissions an additional 1000L-scale GMP production line for proteins and completes the construction phase of its virus manufacturing unit.

Author Image

By: Charlie Sternberg

Associate Editor

ProBioGen has expanded both protein and virus manufacturing at its Berlin headquarters—including the commissioning of an additional 1000L-scale GMP production line for proteins and the completion of the construction phase of its virus manufacturing unit. “These strategic initiatives mark a major milestone for us as we continue to grow and better fulfill our customer’s needs,” explains Dr. Alfred Merz, Chief Executive Officer at ProBioGen. In the protein vertical, this strategic move ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters